|
ACBD7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.174420E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.200800E-04 |
| Normal-vs-Stage2 |
4.811300E-04 |
| Normal-vs-Stage3 |
4.469400E-01 |
| Normal-vs-Stage4 |
5.782000E-01 |
| Stage1-vs-Stage2 |
1.881610E-01 |
| Stage1-vs-Stage3 |
1.301410E-01 |
| Stage1-vs-Stage4 |
1.767220E-01 |
| Stage2-vs-Stage3 |
8.232400E-02 |
| Stage2-vs-Stage4 |
1.159390E-01 |
| Stage3-vs-Stage4 |
8.799800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.400100E-03 |
| Normal-vs-AfricanAmerican |
3.993200E-01 |
| Normal-vs-Asian |
9.696800E-01 |
| Caucasian-vs-AfricanAmerican |
8.342300E-02 |
| Caucasian-vs-Asian |
3.499000E-01 |
| AfricanAmerican-vs-Asian |
7.464800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.325800E-02 |
| Normal-vs-Female |
9.801800E-01 |
| Male-vs-Female |
1.039990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.542200E-01 |
| Normal-vs-Extreme_Weight |
1.68327999999773E-05 |
| Normal-vs-Obese |
7.531600E-01 |
| Normal-vs-Extreme_Obese |
2.210400E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.593700E-02 |
| Normal_Weight-vs-Obese |
3.288000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.162600E-01 |
| Extreme_Weight-vs-Obese |
3.498100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.592200E-01 |
| Obese-vs-Extreme_Obese |
8.726300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.972550E-01 |
| Normal-vs-Age(41-60Yrs) |
8.465600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.438300E-04 |
| Normal-vs-Age(81-100Yrs) |
5.0198000001167E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.008800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.347700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.678300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.383660E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.30380000000908E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.557700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.517700E-02 |
| Normal-VS-Type2 PRCC |
2.982000E-01 |
| Normal-VS-KIRP CIMP |
1.995520E-02 |
| Normal-VS-Unclassified PRCC |
1.130080E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.823200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.700700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.422800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.539400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.237200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.497600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.930200E-01 |
| Normal-vs-N1 |
3.176200E-02 |
| Normal-vs-N2 |
4.592400E-01 |
| N0-vs-N1 |
3.550300E-02 |
| N0-vs-N2 |
2.996000E-01 |
| N1-vs-N2 |
9.340000E-01 |
|
|
